Table 5.
DNA commercialization typology
| Types of commercial engagement | Modifying factors |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| object to be commercialized (e.g., samples, data) | source: individuals, groups, populations | identity of commercial entity | consent | community engagement | end use and users | potential harms/concerns | potential benefits | role of intermediary (e.g., governance structures) | |
| Partnership Clinical translation/product development Research by commercial entity Infrastructure Buying and selling | |||||||||